Arthrocell plus allograft, 5.0CC
Ended Awarded Last action
- Contract number
- SPE2D626F90C3
- Awardee
-
Arthrex Inc. UEI JAXJXHWLD8N1
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,602
Award facts
- Contract value 100% obligated
- $28,601.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Naples, FL 34108, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded Arthrex Inc. a $28.6K delivery order on January 7, 2026, for ARTHROCELL PLUS ALLOGRAFT, 5.0CC—a biologic orthopedic product. This fixed-price delivery order with economic price adjustment will be fulfilled from Arthrex's Naples, Florida headquarters and is scheduled for completion by January 12, 2026. The award was made without a set-aside designation, reflecting Arthrex's competitive standing as a primary orthopedic supplier to federal healthcare systems. This delivery order operates under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with DLA Medical Supply Chain, a $471M master agreement effective through September 1, 2029, that authorizes procurement of comprehensive orthopedic solutions for Department of Veterans Affairs and Department of Defense healthcare facilities nationwide.
Arthrex Inc., a leading minimally invasive orthopedic medical technology manufacturer, serves as the prime contractor with no subcontractors involved. The company specializes in surgical implants, arthroscopic instruments, joint replacement systems, and advanced biologic products supporting orthopedic procedures across multiple surgical specialties. Under the parent IDC vehicle, Arthrex supplies both VA medical centers and military healthcare facilities across multiple Veterans Integrated Service Networks, enabling rapid procurement of advanced orthopedic solutions for veteran and active-duty patient populations. The ARTHROCELL PLUS ALLOGRAFT product represents part of Arthrex's broader biologic portfolio supporting comprehensive orthopedic surgical care.
Quick answers
Who was awarded contract SPE2D626F90C3?
SPE2D626F90C3 was awarded to Arthrex Inc. by Medical Supply Chain (Troop Support) on January 7, 2026.
How much is contract SPE2D626F90C3 worth?
The government has obligated $28,602 on SPE2D626F90C3.
Is contract SPE2D626F90C3 an order under another contract?
Yes. SPE2D626F90C3 is a delivery order under SPE2DE24DA017, an indefinite delivery contract.
Was contract SPE2D626F90C3 competed?
The extent of competition for SPE2D626F90C3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award